Cytiva

Company Overview

Cytiva offers a wide range of services and technologies that promote and expedite the development and production of various therapeutics. Cytiva expanded its portfolio to include market-leading brands in 2023 after completing a large integration with Pall Corp.'s Life Sciences division. It is an essential technical partner and supplier to the biotechnology and pharmaceutical sectors. Its products encompass every aspect of bioprocessing, including process development, discovery, and large-scale production in a variety of modalities, including mRNA, cell and gene treatments, and monoclonal antibodies. Well-known brands, including ÄKTA, Amersham, Biacore, FlexFactory, HyClone, MabSelect, Sefia, Whatman, Xcellerex, and Xuri, are among the many products in Cytiva’s broad range. Formerly known as GE Healthcare Life Sciences, in 2020, Danaher Corp. acquired Cytiva, but it has been operating under the brand name Cytiva.

Company's Business Segments

• Products : Aseptic filling, Bioprocess filtration, Cell culture and fermentation processes, Cell therapy solutions, Chromatography products, Fluid management, Lab filtration, Lipid nanoparticle instruments and reagents, Medical products, Diagnostics, Oligonucleotide synthesis, Protein analysis equipment and supplies
• Services : LifeCycle support solutions, Regulatory support, Change Control Notifications, Scientific support, Certificate search, Handbooks, Instructions for use, Safety data sheets/SDS, Tools and calculators, Training